載入...
Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis
Myasthenia gravis (MG) is a rare debilitating autoimmune neuromuscular disorder. Many studies have focused on the mechanism and treatment strategies of MG. However, the exact pathogenesis of MG and effective treatment strategies remain unclear. Recent studies have indicated that microRNAs (miRNAs or...
Na minha lista:
| 發表在: | Int J Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5358695/ https://ncbi.nlm.nih.gov/pubmed/28075449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2017.2853 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|